Full Opinion

Case: 26-2055 Document: 20 Page: 1 Filed: 11/12/2026 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ FERRING PHARMACEUTICALS INC., FERRING MICROBIOME INC., fka Rebiotix Inc., Plaintiffs/Counterclaim Defendants-Appellants v. FINCH THERAPEUTICS GROUP, INC., FINCH THERAPEUTICS HOLDINGS, LLC., FINCH THERAPEUTICS, INC., Defendants/Counterclaim Plaintiffs-Cross-Appellants REGENTS OF THE UNIVERSITY OF MINNESOTA, Counterclaim Plaintiff-Cross-Appellant ______________________ 2026-2055, 2026-2089 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:21-cv-01694-JLH, Judge Jennifer L. Hall. ______________________ ORDER The parties having so agreed, it is ordered that: Case: 26-2055 Document: 20 Page: 2 Filed: 11/12/2026 2 FERRING PHARMACEUTICALS INC. V. FINCH THERAPEUTICS GROUP, INC. (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b). (2) Each side shall bear their own costs. FOR THE COURT November 12, 2026 Date ISSUED AS A MANDATE: November 12, 2026